CEO defends Merck on Vioxx Merck  amp; Co.'s chairman and chief executive Raymond Gilmartin yesterday defended his firm's handling of earlier health warnings about Vioxx and said he was  quot;stunned quot; when he learned two weeks ago that a Merck clinical trial had confirmed the drug could cause strokes and heart attacks.